Institutional Biosafety Committee (IBC)

Unique in the nation, our affiliates send representation to an independent biosafety committee to review recombinant DNA/gene transfer research. Our core committee is composed of chairs and biosafety officers from academic centers. With this mechanism and without sacrificing scrupulous oversight safety, a trial involving recombinant DNA/gene transfer may be started much more expeditiously than in the past.

IBC Forms and Downloads

IBC Services provided by BRANY include:

  • Formation of IBC where needed
    • Core board of gene transfer and biosafety experts from academic centers
    • Network of non-affiliated community members
    • Biosafety officers for site inspection
    • Facilitation of all administrative requirements, including IBC registration and required reporting
  • Expert review and consideration, including:
    • Safety Considerations
      • Risk Assessment
      • Containment levels
      • Assessment of the facilities, procedures, practices, and training an expertise of personnel involved
    • Appendix M
    • RAC Review (if applicable)
    • Surveillance, data reporting, and adverse event reporting requirements set forth in the NIH Guidelines
  • Ongoing oversight by IBC (continuing review)
  • Personalized and responsive service with assigned project coordinator, including:
    • Selection of appropriate IBC members
    • Registration of IBC with OBA/NIH
    • Review of IBC applications for completeness
    • Scheduling IBC meetings for initial and continuing review
    • Preparation of meeting agenda and distribution of materials for review
    • Correspondence between site, sponsor, IBC, and NIH
    • Maintenance of appropriate project records and minutes of IBC meetings
    • Scheduling site visits as needed
  • Meetings scheduled on request
  • Very competitive and transparent pricing (fees available upon request).

BRANY IBC Process Outline
For more information please contact
Vanessa Rodriguez
Phone: 516.514.2445